AzTrials
AzTrials

Skin NeoplasmNCT05788939

PLANNED VISUAL EDUCATION ABOUT SKIN CANCER

A study testing Planned Visual Education Based on Health Belief Model in people with Skin Neoplasm, run by Manisa Celal Bayar University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to evaluate the effect of planned visual education based on the Health Belief Model on university students' attitudes and beliefs toward skin cancer. The planned visual education based in Health Belief Model has possitive effects on univestiy students' attitudes and beliefs toward skin cancer. Read more about this study

Who is it for?
Ages 18 to 24 yearsHealthy volunteers can take part
Conditions the study is for
Skin Neoplasm
What is being tested?
Planned Visual Education Based on Health Belief Model
Could I receive a placebo?
No, everyone receives an active treatment
How many people
116 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Feb 2019to 30 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 24 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • who Registered and continuing department courses
  • who agreed to participate in the study
  • who had formal education
  • who been second year students

Who cannot join

  • Registration and absence of the student in the department courses
  • Refusal to participate in the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site

  • CelalBayarU

    Manisa

Other trials in Turkey (Türkiye)

About this study

Official title: DOES PLANNED VISUAL EDUCATION AFFECT UNIVERSITY STUDENTS' ATTITUDES AND BELIEFS ABOUT SKIN CANCER?

This study aimed to evaluate the effect of planned visual education based on the Health Belief Model on university students' attitudes and beliefs toward skin cancer. The planned visual education based in Health Belief Model has possitive effects on univestiy students' attitudes and beliefs toward skin cancer.

Read the detailed description

This study aimed to evaluate the effect of planned visual education based on the Health Belief Model on university students' attitudes and beliefs toward skin cancer. Planned as a cluster-randomized controlled experimental study conducted on two groups (n=116). The study was carried out in Faculty of Economics and Administrative Sciences (FEAS) and Hasan Ferdi Turgutlu Faculty of Technology (HFTFT) from the faculties of Manisa Celal Bayar University (MCBU) between February-Semptember 2019. Among seven departments in FEAS and four departments in the HFTFT, simple random sampling was used to draw lots again. The Department of Econometrics from the FEAS was assigned as the intervation groups (n=58) and Mechatronics Engineering from HFTFT was assigned as the control group (n=58). Data were collected using The Student Introduction Form and The Health Belief Model Scale in Skin Cancer.

Conditions
Skin Neoplasm
Being tested
Planned Visual Education Based on Health Belief Model
Keywords
Health belief model, health attitudes, university students, skin cancer
Medical subject headings
Skin Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Planned Visual Education Based on Health Belief ModelOther

    The students in IG were administered the planned visual education based on Health Belief Model for a period of seven months.

    The education materials were a PowerPoint presentation, a skin cancer model, videos titled "Dear 16 years old me", "Mr. Sun", a brochure, and 3 posters.

    .

Study groups in NCT05788939
Study groupRoleWhat they receive
intervention groupExperimentalThe sample of this cluster randomized controlled experimental study consisted of 2nd year university students (n=116) training in Faculty of Economics and Administrative Sciences (FEAS) and Hasan Ferdi Turgutlu Faculty of Technology (HFTFT) from the faculties of Manisa Celal Bayar University (MCBU) between February-Semptember 2019. Among the faculties in MCBU, simple random sampling was used to draw lots, with the first lot being assigned to FEAS as the intervention group (IG), and the second lot being assigned to HFTFT as the control group (CG) . Among seven departments in FEAS and four departments in the HFTFT, simple random sampling was used to draw lots again. The Department of Econometrics from the FEAS was assigned as the IG and Mechatronics Engineering from HFTFT was assigned as the CG. The planned visual education based Health Belief Model was given.
Receives: Other: Planned Visual Education Based on Health Belief Model
Control groupNo interventionNo attempt was made by researcher during the study. Only data were collected. At the end of the study, the planned visual education based Health Belief Model was given and all students continued in the study were given key rings with pictures about sun protection designed by the researchers.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Health Belief Model Scale in Skin Cancer

    Developed by Dogan and Caydam (2021), the scale consists of 26 items and 5 sub-dimensions (perceived susceptibility, perceived benefit, perceived severity, perceived barriers, and self-efficacy). The HBMSSC is a five-point Likert-type scale, and each item is answered from "disagree=1" to "strongly agree=5". The total Cronbach's alpha coefficient of the scale is 0.86, and for the sub-dimensions it is 0.89; 0.79; 0.77; 0.65 and 0.86, respectively. The "perceived barriers" sub-dimension of the scale is reverse coded. The scale does not have a total score, and each sub-dimension is scored within itself. Higher "perceived susceptibility, "perceived benefit, "perceived severity", and "self-efficacy" scores indicate higher perceived susceptibility, perceived benefit, perceived severity, and self-efficacy

    Measured: One months

  2. The Health Belief Model Scale in Skin Cancer

    Developed by Dogan and Caydam (2021), the scale consists of 26 items and 5 sub-dimensions (perceived susceptibility, perceived benefit, perceived severity, perceived barriers, and self-efficacy). The HBMSSC is a five-point Likert-type scale, and each item is answered from "disagree=1" to "strongly agree=5". The total Cronbach's alpha coefficient of the scale is 0.86, and for the sub-dimensions it is 0.89; 0.79; 0.77; 0.65 and 0.86, respectively. The "perceived barriers" sub-dimension of the scale is reverse coded. The scale does not have a total score, and each sub-dimension is scored within itself. Higher "perceived susceptibility, "perceived benefit, "perceived severity", and "self-efficacy" scores indicate higher perceived susceptibility, perceived benefit, perceived severity, and self-efficacy

    Measured: Three months

  3. The Health Belief Model Scale in Skin Cancer

    Developed by Dogan and Caydam (2021), the scale consists of 26 items and 5 sub-dimensions (perceived susceptibility, perceived benefit, perceived severity, perceived barriers, and self-efficacy). The HBMSSC is a five-point Likert-type scale, and each item is answered from "disagree=1" to "strongly agree=5". The total Cronbach's alpha coefficient of the scale is 0.86, and for the sub-dimensions it is 0.89; 0.79; 0.77; 0.65 and 0.86, respectively. The "perceived barriers" sub-dimension of the scale is reverse coded. The scale does not have a total score, and each sub-dimension is scored within itself. Higher "perceived susceptibility, "perceived benefit, "perceived severity", and "self-efficacy" scores indicate higher perceived susceptibility, perceived benefit, perceived severity, and self-efficacy

    Measured: Seven months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Mar 2023
  2. Study start1 Feb 2019
  3. Primary completion20 Sep 2019
  4. Study completion30 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
The sample of this cluster randomized controlled experimental study consisted of 2nd year university students (n=116) training in Faculty of Economics and Administrative Sciences (FEAS) and Hasan Ferdi Turgutlu Faculty of Technology (HFTFT) from the faculties of Manisa Celal Bayar University (MCBU) between February-Semptember 2019. Among the faculties in MCBU, simple random sampling was used to draw lots, with the first lot being assigned to FEAS as the intervention group (IG), and the second lot being assigned to HFTFT as the control group (CG) . Among seven departments in FEAS and four departments in the HFTFT, simple random sampling was used to draw lots again. The Department of Econometrics from the FEAS was assigned as the IG and Mechatronics Engineering from HFTFT was assigned as the CG. 58 students for the CG and 58 students for the IG were recruited for the sample. Power of the study was calculated as post hoc at α=0.05 with a significance of 0.95.
Masking
Single blind
Who is masked
Participant
Enrolment
116 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05788939
Sponsor's protocol ID
2018-186
Status last verified
Jun 2023
First submitted
2 Mar 2023
Last updated
15 Jun 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: ll IPD that underlie results in a publication

Publications

  • Barbaric J, Sekerija M, Agius D, Coza D, Dimitrova N, Demetriou A, Safaei Diba C, Eser S, Gavric Z, Primic-Zakelj M, Zivkovic S, Zvolsky M, Bray F, Coebergh JW, Znaor A. Disparities in melanoma incidence and mortality in South-Eastern Europe: Increasing incidence and divergent mortality patterns. Is progress around the corner? Eur J Cancer. 2016 Mar;55:47-55. doi: 10.1016/j.ejca.2015.11.019. Epub 2016 Jan 9.

    PubMed 26773419

  • Livingstone E, Windemuth-Kieselbach C, Eigentler TK, Rompel R, Trefzer U, Nashan D, Rotterdam S, Ugurel S, Schadendorf D. A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up. Eur J Cancer. 2011 Sep;47(13):1977-89. doi: 10.1016/j.ejca.2011.04.029. Epub 2011 May 24.

    PubMed 21612915

  • Birch-Johansen F, Jensen A, Mortensen L, Olesen AB, Kjaer SK. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: Rapid incidence increase among young Danish women. Int J Cancer. 2010 Nov 1;127(9):2190-8. doi: 10.1002/ijc.25411.

    PubMed 20473901

  • Karagas MR, Zens MS, Li Z, Stukel TA, Perry AE, Gilbert-Diamond D, Sayarath V, Stephenson RS, Barton D, Nelson HH, Spencer SK. Early-onset basal cell carcinoma and indoor tanning: a population-based study. Pediatrics. 2014 Jul;134(1):e4-12. doi: 10.1542/peds.2013-3559.

    PubMed 24958589

  • Armstrong AW, Idriss NZ, Kim RH. Effects of video-based, online education on behavioral and knowledge outcomes in sunscreen use: a randomized controlled trial. Patient Educ Couns. 2011 May;83(2):273-7. doi: 10.1016/j.pec.2010.04.033. Epub 2010 Jun 1.

    PubMed 20570081

  • Stanton WR, Chakma B, O'Riordan DL, Eyeson-Annan M. Sun exposure and primary prevention of skin cancer for infants and young children during autumn/winter. Aust N Z J Public Health. 2000 Apr;24(2):178-84. doi: 10.1111/j.1467-842x.2000.tb00139.x.

    PubMed 10790938

  • Wesson KM, Silverberg NB. Sun protection education in the United States: what we know and what needs to be taught. Cutis. 2003 Jan;71(1):71-4, 77.

    PubMed 12553634

  • Makin JK, Warne CD, Dobbinson SJ, Wakefield MA, Hill DJ. Population and age-group trends in weekend sun protection and sunburn over two decades of the SunSmart programme in Melbourne, Australia. Br J Dermatol. 2013 Jan;168(1):154-61. doi: 10.1111/bjd.12082.

    PubMed 23039760

  • Celik S, Ilce A, Andsoy II. Knowledge and Protective Behaviors About Skin Cancer Among Nursing Students in the West Black Sea Region of Turkey. J Cancer Educ. 2018 Aug;33(4):885-892. doi: 10.1007/s13187-017-1188-5.

    PubMed 28229313

  • Balyaci OE, Kostu N, Temel AB. Training program to raise consciousness among adolescents for protection against skin cancer through performance of skin self examination. Asian Pac J Cancer Prev. 2012;13(10):5011-7. doi: 10.7314/apjcp.2012.13.10.5011.

    PubMed 23244101

  • Glanz K, Steffen AD, Schoenfeld E, Tappe KA. Randomized trial of tailored skin cancer prevention for children: the Project SCAPE family study. J Health Commun. 2013;18(11):1368-83. doi: 10.1080/10810730.2013.778361. Epub 2013 Jun 27.

    PubMed 23806094

  • Nahar VK, Ford MA, Hallam JS, Bass MA, Hutcheson A, Vice MA. Skin Cancer Knowledge, Beliefs, Self-Efficacy, and Preventative Behaviors among North Mississippi Landscapers. Dermatol Res Pract. 2013;2013:496913. doi: 10.1155/2013/496913. Epub 2013 Oct 7.

    PubMed 24223037

  • Haney MO, Bahar Z, Beser A, Arkan G, Cengiz B. Psychometric Testing of the Turkish Version of the Skin Cancer and Sun Knowledge Scale in Nursing Students. J Cancer Educ. 2018 Feb;33(1):21-28. doi: 10.1007/s13187-016-1041-2.

    PubMed 27155664

  • Khani Jeihooni A, Hidarnia A, Kaveh MH, Hajizadeh E. The effect of a prevention program based on health belief model on osteoporosis. J Res Health Sci. 2015 Winter;15(1):47-53.

    PubMed 25821026

  • Kissal A, Kartal B. Effects of Health Belief Model-Based Education on Health Beliefs and Breast Self-Examination in Nursing Students. Asia Pac J Oncol Nurs. 2019 Oct-Dec;6(4):403-410. doi: 10.4103/apjon.apjon_17_19.

    PubMed 31572761

Questions about this trial

What is this clinical trial studying?

A study testing Planned Visual Education Based on Health Belief Model in people with Skin Neoplasm, run by Manisa Celal Bayar University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Health Belief Model Scale in Skin Cancer (time frame: One months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05788939, which also lists 18 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2023.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in